AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9990599 — intervention group
Group type: EXPERIMENTAL
Intervention: High impedance steroid‐eluting pacing leads (Medtronic model 5534 and 5034)
Number of subjects: 609
Study 9990599 — intervention group
Group type: COMPARATOR
Intervention: Standard steroid‐eluting pacing leads (Medtronic model 5524 and 5024)
Number of subjects: 609
Study 9990599 — intervention group
Group type: EXPERIMENTAL
Intervention: High impedance steroid‐eluting pacing leads (Medtronic model 5534)
Number of subjects: 609
Study 9990599 — intervention group
Group type: COMPARATOR
Intervention: Standard steroid‐eluting pacing leads (Medtronic model 5524)
Number of subjects: 609
Study 9990599 — intervention group
Group type: EXPERIMENTAL
Intervention: High impedance steroid‐eluting pacing leads (Medtronic model 5034)
Number of subjects: 609
Study 9990599 — intervention group
Group type: COMPARATOR
Intervention: Standard steroid‐eluting pacing leads (Medtronic model 5024)
Number of subjects: 609
Study 9990599 — intervention group
Group type: EXPERIMENTAL
Intervention: High impedance leads
Number of subjects: 609
Study 7579565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 20 mg/m2 in 15 min i.v. infusion followed by FA 500 mg/m2 in 1 h i.v. infusion, with 5-FU 500 mg/m2 i.v. bolus administered in the middle, repeated weekly for 4 weeks followed by a 2 week rest, for a maximum of six cycles.
Number of subjects: 30
Study 1377769 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic substance P (SP) at doses of 0.5, 1.0, or 1.5 pmol/kg‐1/min‐1 for 60 minutes
Number of subjects: 7
Study 1377769 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 7
Study 6373161 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (25 to 150 mg)
Number of subjects: 33
Study 6373161 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (10 to 30 mg)
Number of subjects: 33
Study 31404538 — intervention group
Group type: EXPERIMENTAL
Intervention: My Birth Control (intervention)
Number of subjects: 15
Study 30367647 — intervention group
Group type: EXPERIMENTAL
Intervention: PMX‐HP
Number of subjects: 59
Study 30367647 — intervention group
Group type: COMPARATOR
Intervention: non‐PMX‐HP
Number of subjects: 59
Study 30367647 — intervention group
Group type: COMPARATOR
Intervention: PMX‐HP and non‐PMX‐HP
Number of subjects: 59
Study 27605966 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 100
Study 27605966 — intervention group
Group type: COMPARATOR
Intervention: Resisted exercise training for 12 weeks
Number of subjects: 100
Study 24590257 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term antidepressant medication
Number of subjects: 458
Study 24590257 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing antipsychotic medication
Number of subjects: 458
Study 24590257 — intervention group
Group type: EXPERIMENTAL
Intervention: No further antidepressant treatment
Number of subjects: 458
Study 24590257 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple hospitalizations
Number of subjects: 458
Study 24590257 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidant personality disorder
Number of subjects: 458
Study 23681396 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 200
Study 23681396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 23681396 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin and Placebo
Number of subjects: 200
Study 21855742 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (12-month duration)
Number of subjects: 177
Study 21855742 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulatory strategies and executive function
Number of subjects: 177
Study 21855742 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 177
Study 21855742 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of exercise classes attended
Number of subjects: 177
Study 19282169 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5mg/day (morning dosing)
Number of subjects: 60
Study 19282169 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5mg/day (evening dosing)
Number of subjects: 60
Study 19282169 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5mg/day (both morning and evening dosing)
Number of subjects: 60
Study 17908580 — intervention group
Group type: EXPERIMENTAL
Intervention: 2/100Hz alternating frequency TENS
Number of subjects: 64
Study 17908580 — intervention group
Group type: EXPERIMENTAL
Intervention: 100Hz TENS
Number of subjects: 64
Study 17908580 — intervention group
Group type: EXPERIMENTAL
Intervention: 2Hz TENS
Number of subjects: 64
Study 17908580 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 64
Study 15281507 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal group (TIVA with propofol, droperidol, and ondansetron)
Number of subjects: 90
Study 15281507 — intervention group
Group type: COMPARATOR
Intervention: Combination group (droperidol and ondansetron with isoflurane and nitrous oxide)
Number of subjects: 90
Study 15281507 — intervention group
Group type: COMPARATOR
Intervention: TIVA group (propofol for induction and maintenance)
Number of subjects: 90
Study 11525372 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic preperitoneal 'bikini mesh' hernia repair (TAPP)
Number of subjects: 43
Study 11525372 — intervention group
Group type: COMPARATOR
Intervention: Open Lichtenstein hernioplasty
Number of subjects: 43
Study 9603532 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg daily)
Number of subjects: 522
Study 9603532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study 7549773 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of control and inability to abstain measures
Number of subjects: 97
Study 2180861 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation technique (slow, deep-breathing)
Number of subjects: 29
Study 2180861 — intervention group
Group type: COMPARATOR
Intervention: Control (no relaxation training)
Number of subjects: 29
Study 7406249 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone 2 mg/kg/day
Number of subjects: 16
Study 7406249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30823922 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 7
Study 30823922 — intervention group
Group type: COMPARATOR
Intervention: Palm oil
Number of subjects: 7
Study 30823922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 28350928 — intervention group
Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 760
Study 28350928 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 760
Study 26359031 — intervention group
Group type: EXPERIMENTAL
Intervention: Current use of meloxicam
Number of subjects: 6780
Study 26359031 — intervention group
Group type: EXPERIMENTAL
Intervention: Late use of meloxicam
Number of subjects: 6780
Study 26359031 — intervention group
Group type: COMPARATOR
Intervention: Never used meloxicam
Number of subjects: 6780
Study 23799528 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone treatment
Number of subjects: 225
Study 21350199 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (alteplase)
Number of subjects: 1699
Study 21350199 — intervention group
Group type: COMPARATOR
Intervention: Non-thrombolyzed comparators
Number of subjects: 1699
Study 19186729 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-moxibustion group
Number of subjects: 86
Study 19186729 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture group
Number of subjects: 86
Study 17263767 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.4 g/kg) during hypoglycaemia (2.8 mmol/l for 65 min)
Number of subjects: 17
Study 17263767 — intervention group
Group type: COMPARATOR
Intervention: Placebo during hypoglycaemia (2.8 mmol/l for 65 min)
Number of subjects: 17
Study 17263767 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.4 g/kg) during euglycaemia
Number of subjects: 17
Study 17263767 — intervention group
Group type: COMPARATOR
Intervention: Placebo during euglycaemia
Number of subjects: 17
Study 15093870 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine 500 mg twice daily
Number of subjects: 191
Study 15093870 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine 1000 mg twice daily
Number of subjects: 191
Study 15093870 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine 1500 mg twice daily
Number of subjects: 191
Study 15093870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study 15093870 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine (all doses)
Number of subjects: 191
Study 15093870 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 191
Study 11208222 — intervention group
Group type: EXPERIMENTAL
Intervention: Vectored upper cervical (atlas) adjustment
Number of subjects: 80
Study 11208222 — intervention group
Group type: COMPARATOR
Intervention: Resting control
Number of subjects: 80
Study 11208222 — intervention group
Group type: EXPERIMENTAL
Intervention: Postrest to postadjustment readings
Number of subjects: 80
Study 11208222 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre/post drop in systolic pressure
Number of subjects: 80
Study 11208222 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre/postrest change in systolic blood pressure
Number of subjects: 80
Study 9274262 — intervention group
Group type: EXPERIMENTAL
Intervention: New polyurethane foam dressing
Number of subjects: 61
Study 9274262 — intervention group
Group type: COMPARATOR
Intervention: Hydrocellular dressing
Number of subjects: 61
Study 8173750 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas-exchange method (VO2GE)
Number of subjects: 10
Study 8173750 — intervention group
Group type: EXPERIMENTAL
Intervention: Fick method (VO2F)
Number of subjects: 10
Study 8173750 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermodilution with iced saline
Number of subjects: 10
Study 8173750 — intervention group
Group type: COMPARATOR
Intervention: Thermodilution with room temperature saline
Number of subjects: 10
Study 8173750 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermodilution with room temperature saline (end expiration)
Number of subjects: 10
Study 2311729 — intervention group
Group type: EXPERIMENTAL
Intervention: Education at asthma school
Number of subjects: 40
Study 2311729 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education at asthma school)
Number of subjects: 40
Study 254058 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsogluteal injection with femur internally rotated (narcotic medication)
Number of subjects: 44
Study 254058 — intervention group
Group type: COMPARATOR
Intervention: Dorsogluteal injection with femur externally rotated (narcotic medication)
Number of subjects: 44
Study 254058 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsogluteal injection with femur internally rotated (diazepam)
Number of subjects: 44
Study 254058 — intervention group
Group type: COMPARATOR
Intervention: Dorsogluteal injection with femur externally rotated (diazepam)
Number of subjects: 44
Study 254058 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsogluteal injection (diazepam)
Number of subjects: 44
Study 31232909 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (n = 8)
Number of subjects: 15
Study 31232909 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (n = 6)
Number of subjects: 15
Study 28264631 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 14
Study 28264631 — intervention group
Group type: EXPERIMENTAL
Intervention: McConnell taping
Number of subjects: 14
Study 28264631 — intervention group
Group type: COMPARATOR
Intervention: No tape
Number of subjects: 14
Study 25677380 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole 2.5 mg kg(‐1) orally once every other day
Number of subjects: 38
Study 25677380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 23462343 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic lifestyle intervention delivered via group classes and individual motivational interviewing sessions
Number of subjects: 250
Study 23462343 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 250
Study 23462343 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic lifestyle intervention
Number of subjects: 250
Study 22146172 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality simulator training (4 training sessions)
Number of subjects: 26
Study 22146172 — intervention group
Group type: COMPARATOR
Intervention: No training (Control group)
Number of subjects: 26
Study 19762512 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 0
Study 19762512 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 17330831 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1700 mg/day)
Number of subjects: 40
Study 17330831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15129980 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal clotrimazole cream
Number of subjects: 8
Study 15129980 — intervention group
Group type: EXPERIMENTAL
Intervention: Test gel product
Number of subjects: 8
Study 11556579 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of albendazole 400 mg (A1, n=34)
Number of subjects: 173
Study 11556579 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 days of albendazole 400 mg daily (A3, n=34)
Number of subjects: 173
Study 11556579 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 days of albendazole 400 mg daily (A5, n=35)
Number of subjects: 173
Study 11556579 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of albendazole 400 mg plus praziquantel 40 mg/kg (AIP1, n=34)
Number of subjects: 173
Study 11556579 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 days of albendazole 400 mg plus praziquantel 40 mg/kg daily (A3P3, n=36)
Number of subjects: 173
Study 9563866 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA using propofol with alfentanil (high infusion rate)
Number of subjects: 73
Study 9563866 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA using propofol with alfentanil (low infusion rate)
Number of subjects: 73
Study 9563866 — intervention group
Group type: COMPARATOR
Intervention: Sodium thiopentone induction and inhalational maintenance (isoflurane)
Number of subjects: 73
Study 7910733 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Eye Movement Desensitization (REMD)
Number of subjects: 0
Study 7910733 — intervention group
Group type: COMPARATOR
Intervention: Slow Eye Movement Desensitization (SEMD)
Number of subjects: 0
Study 7910733 — intervention group
Group type: COMPARATOR
Intervention: Stationary-Imagery (SI)
Number of subjects: 0
Study 3306994 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 63
Study 3306994 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin and Gentamicin
Number of subjects: 63
Study 3306994 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin and Clindamycin and Gentamicin
Number of subjects: 63
Study 30365428 — intervention group
Group type: EXPERIMENTAL
Intervention: Do then See
Number of subjects: 36
Study 30365428 — intervention group
Group type: COMPARATOR
Intervention: See then Do
Number of subjects: 36
Study 30634206 — intervention group
Group type: EXPERIMENTAL
Intervention: WM + HD group (60 cases)
Number of subjects: 120
Study 30634206 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group (60 cases)
Number of subjects: 120
Study 24710341 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide 500 mg
Number of subjects: 80
Study 24710341 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide 250 mg
Number of subjects: 80
Study 24710341 — intervention group
Group type: COMPARATOR
Intervention: Discontinuation of CPAP therapy
Number of subjects: 80
Study 24710341 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoCPAP
Number of subjects: 80
Study 22727324 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomics Trained
Number of subjects: 22
Study 22727324 — intervention group
Group type: COMPARATOR
Intervention: Minimally Trained
Number of subjects: 22
Study 20707248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) group: hyperbaric bupivacaine 15 mg plus 100 mcg of preservative-free morphine
Number of subjects: 52
Study 20707248 — intervention group
Group type: COMPARATOR
Intervention: Single-shot ultrasound-guided femoral nerve block (FNB) group: ropivacaine 0.75% 25 ml
Number of subjects: 52
Study 18387655 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% fat-based diet
Number of subjects: 20
Study 18387655 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% fat-based diet
Number of subjects: 20
Study 18387655 — intervention group
Group type: COMPARATOR
Intervention: Normal activity after six weeks
Number of subjects: 20
Study 16857890 — intervention group
Group type: EXPERIMENTAL
Intervention: NREM delta power density (DPD)
Number of subjects: 69
Study 12807337 — intervention group
Group type: EXPERIMENTAL
Intervention: EPs 7630 (30 drops three times daily for 7 days)
Number of subjects: 468
Study 12807337 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 drops three times daily for 7 days)
Number of subjects: 468
Study 12807337 — intervention group
Group type: EXPERIMENTAL
Intervention: EPs 7630
Number of subjects: 468
Study 12807337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study 12024594 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular low level He‐Ne laser irradiation
Number of subjects: 58
Study 12024594 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 58
Study 8865711 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with 0.5% isoflurane, nitrous oxide and oxygen supplemented with epidural analgesia
Number of subjects: 27
Study 8865711 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with isoflurane, nitrous oxide and oxygen
Number of subjects: 27
Study 8865711 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced anesthesia with 0.5% isoflurane, nitrous oxide, oxygen and intravenous fentanyl
Number of subjects: 27
Study 8865711 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 27
Study 1510899 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam administered in conscious sedation doses
Number of subjects: 20
Study 6084856 — intervention group
Group type: COMPARATOR
Intervention: Irradiation alone (35 Gy)
Number of subjects: 0
Study 6084856 — intervention group
Group type: COMPARATOR
Intervention: Irradiation (30 Gy) and bleomycin (5 mg i.m. 1/2‐1 h before each irradiation)
Number of subjects: 0
Study 6084856 — intervention group
Group type: COMPARATOR
Intervention: Irradiation alone (63 Gy)
Number of subjects: 0
Study 6084856 — intervention group
Group type: COMPARATOR
Intervention: Irradiation (55 Gy) and bleomycin (5 mg i.m. 1/2‐1 h before each irradiation)
Number of subjects: 0
Study 6084856 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin and adriamycin treatment
Number of subjects: 0
Study 6084856 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical operation
Number of subjects: 0
Study 6084856 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation with or without bleomycin
Number of subjects: 0
Study 6084856 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation with or without bleomycin in operable patients
Number of subjects: 0
Study 30626264 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention details not available)
Number of subjects: 319
Study 30626264 — intervention group
Group type: COMPARATOR
Intervention: Control group (specific control details not available)
Number of subjects: 319
Study 30542024 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to vigorous physical activity (MVPA)
Number of subjects: 450
Study 26634942 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal 0.50% (6.5 mg) DHEA administered daily for 12 weeks
Number of subjects: 373
Study 26634942 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered daily for 12 weeks
Number of subjects: 373
Study 25283469 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite of 5 daily pain intensity ratings
Number of subjects: 0
Study 25283469 — intervention group
Group type: COMPARATOR
Intervention: Single daily pain intensity rating
Number of subjects: 0
Study 22033702 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPI)
Number of subjects: 40
Study 22033702 — intervention group
Group type: COMPARATOR
Intervention: No intervention (off PPI)
Number of subjects: 40
Study 18807079 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse transit time (PTT) measurement before orthodontic treatment
Number of subjects: 8
Study 18807079 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse transit time (PTT) measurement after orthodontic treatment
Number of subjects: 8
Study 18807079 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpretable PTT signal during apnea
Number of subjects: 8
Study 18807079 — intervention group
Group type: COMPARATOR
Intervention: Pre-treatment status
Number of subjects: 8
Study 18807079 — intervention group
Group type: COMPARATOR
Intervention: Type of apnea
Number of subjects: 8
Study 18807079 — intervention group
Group type: COMPARATOR
Intervention: Duration of apnea
Number of subjects: 8
Study 17241859 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week (eow)
Number of subjects: 0
Study 17241859 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg weekly
Number of subjects: 0
Study 17241859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15896617 — intervention group
Group type: EXPERIMENTAL
Intervention: OnP-BH
Number of subjects: 40
Study 15896617 — intervention group
Group type: COMPARATOR
Intervention: OPCAB
Number of subjects: 40
Study 12789992 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% carbamide peroxide gel (Colgate Simply White Clear Whitening Gel) applied twice daily after brushing with a nonwhitening dentifrice
Number of subjects: 80
Study 12789992 — intervention group
Group type: COMPARATOR
Intervention: Commercially available whitening dentifrice used twice daily for brushing
Number of subjects: 80